Ads
related to: nootropics depot phenylpiracetam 10 mg cream
Search results
Results From The WOW.Com Content Network
Phenylpiracetam, also known as fonturacetam (INN Tooltip International nonproprietary name) and sold under the brand names Phenotropil, Actitropil, and Carphedon among others, is a stimulant and nootropic medication used in Russia and certain other Eastern European countries in the treatment of cerebrovascular deficiency, depression, apathy, and attention, and memory problems, among other ...
N-Phenylacetyl-l-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cyclic glycine-proline. [a] [2] Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111, and proposed INN omberacetam. [2] [3] [4] Its synthesis was first reported in 1996. [2] It is orally available.
MRZ-9547, also known as (R)-phenylpiracetam, (R)-phenotropil, or (R)-fonturacetam, is a selective dopamine reuptake inhibitor (IC 50 Tooltip half-maximal inhibitory concentration = 14.5 μM) that was developed by Merz Pharma.
Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. [3] [4] [5] Piracetam is sold as a medication in many European countries.
Nootropic Depot’s capsules are manufactured in facilities that are GMP-certified, with each capsule containing 400 mg of PEA. ... but 300 mg to 600 mg of PEA have been shown to be effective in ...
Methylphenylpiracetam, a derivative of phenylpiracetam, is a positive allosteric modulator of the sigma σ 1 receptor. [10] [13] [14] [15] It is currently the only racetam known to possess this action. [10]
Oxiracetam is well absorbed from the gastrointestinal tract with a bioavailability of 56-82%. [6] Peak serum levels are reached within one to three hours after a single 800 mg or 2000 mg oral dose, with the maximal serum concentration reaching between 19 and 31 μg/ml at these doses.
ALTO-100, previously known as NSI-189 (NeuralStem Inc. 189), [3] is a drug described as a hippocampal neurogenesis stimulant and indirect brain-derived neurotrophic factor (BDNF) modulator which is under development for the treatment of major depressive disorder (MDD), bipolar depression, and post-traumatic stress disorder (PTSD).